BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3102396)

  • 21. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
    Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
    Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation between calcium oxalate hydrate form found in renal calculi and some urinary parameters.
    Conte A; Genestar C; Grases F
    Urol Int; 1990; 45(1):25-7. PubMed ID: 2305491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological observations of the adhesion and endocytosis of calcium oxalate crystals in MDCK cells and in rat and human kidney.
    Ebisuno S; Kohjimoto Y; Tamura M; Inagaki T; Ohkawa T
    Urol Int; 1997; 58(4):227-31. PubMed ID: 9253123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developmental aspects of calcium oxalate tubular deposits and calculi induced in rat kidneys.
    Rushton HG; Spector M; Rodgers AL; Hughson M; Magura CE
    Invest Urol; 1981 Jul; 19(1):52-7. PubMed ID: 7251328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal agglomeration is a major element in calcium oxalate urinary stone formation.
    Kok DJ; Papapoulos SE; Bijvoet OL
    Kidney Int; 1990 Jan; 37(1):51-6. PubMed ID: 2299809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Piridoxilate-associated nephrocalcinosis: a new form of chronic oxalate nephropathy.
    Vigeral P; Kenouch S; Chauveau D; Mougenot B; Méry JP
    Nephrol Dial Transplant; 1987; 2(4):275-8. PubMed ID: 3118272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extract from Herniaria hirsuta coats calcium oxalate monohydrate crystals and blocks their adhesion to renal epithelial cells.
    Atmani F; Farell G; Lieske JC
    J Urol; 2004 Oct; 172(4 Pt 1):1510-4. PubMed ID: 15371881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triamterene and renal stone formation: the influence of triamterene and triamterene stones on calcium oxalate crystallization.
    White DJ; Nancollas GH
    Calcif Tissue Int; 1987 Feb; 40(2):79-84. PubMed ID: 3105837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium oxalate precipitation in a flow system: an attempt to simulate the early stages of stone formation in the renal tubules.
    Azoury R; Garside J; Robertson WG
    J Urol; 1986 Jul; 136(1):150-3. PubMed ID: 3712603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of the oxalate precursors on experimental calcium oxalate urolithogenesis in rats: acute and chronic administration].
    Morozumi M; Ogawa Y
    Nihon Hinyokika Gakkai Zasshi; 1995 May; 86(5):1022-7. PubMed ID: 7596078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic assessment of recurrent and first renal calcium oxalate stone formers.
    Çakıroğlu B; Eyyupoğlu E; Hazar AI; Uyanik BS; Nuhoğlu B
    Arch Ital Urol Androl; 2016 Jul; 88(2):101-5. PubMed ID: 27377084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of uric acid in different types of calcium oxalate renal calculi.
    Grases F; Sanchis P; Perelló J; Costa-Bauzá A
    Int J Urol; 2006 Mar; 13(3):252-6. PubMed ID: 16643619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal macrophage migration and crystal phagocytosis via inflammatory-related gene expression during kidney stone formation and elimination in mice: Detection by association analysis of stone-related gene expression and microstructural observation.
    Okada A; Yasui T; Fujii Y; Niimi K; Hamamoto S; Hirose M; Kojima Y; Itoh Y; Tozawa K; Hayashi Y; Kohri K
    J Bone Miner Res; 2010 Dec; 25(12):2701-11. PubMed ID: 20577968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection.
    Okada A; Nomura S; Higashibata Y; Hirose M; Gao B; Yoshimura M; Itoh Y; Yasui T; Tozawa K; Kohri K
    Urol Res; 2007 Apr; 35(2):89-99. PubMed ID: 17393196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal tubular cell membranes inhibit growth but promote aggregation of calcium oxalate monohydrate crystals.
    Chutipongtanate S; Thongboonkerd V
    Chem Biol Interact; 2010 Dec; 188(3):421-6. PubMed ID: 20797392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers.
    Kok DJ; Papapoulos SE; Bijvoet OL
    Lancet; 1986 May; 1(8489):1056-8. PubMed ID: 2871335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
    Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
    Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change in inhibitory potential in urine of hyperuricosuric calcium oxalate stone formers effected by allopurinol and orthophosphates.
    Goldwasser B; Sarig S; Azoury R; Wax Y; Hirsch D; Perlberg S; Many M
    J Urol; 1984 Nov; 132(5):1008-11. PubMed ID: 6492268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.